https://commons.ufh.ac.za/vital/access/manager/Index ${session.getAttribute("locale")} 5 https://commons.ufh.ac.za/vital/access/manager/Repository/vital:43991 Tue 14 May 2024 11:13:22 SAST ]]> https://commons.ufh.ac.za/vital/access/manager/Repository/vital:43926 75% for both hydrochlorothiazide and captopril. The microparticulate technology is able to offer potential resolution to the half-life mediated dosing frequency of captopril as sustained release of the molecule was observed over a 12-h period. The release of hydrochlorothiazide of >80% suggests an improvement in solubility limited dissolution.]]> Tue 14 May 2024 10:56:57 SAST ]]>